Shaping Statistical Programming in an Era of AI and LLMs скачать в хорошем качестве

Shaping Statistical Programming in an Era of AI and LLMs

As AI and Large Language Models (LLMs) are now also gaining momentum in pharmaceutical clinical development, the discussion on how this will transform statistical programming is intensifying. In this presentation, Richardus Vonk will examine the evolving role of statistical programming within clinical decision-making processes. He will critically evaluate the implications of the renewed promise of automation on current workflows, focusing on the strategic integration of new technology with human expertise. The discussion will address the challenges of maintaining validation, accuracy and scientific integrity as technology and science continue to advance. Attendees will gain actionable insights into the future of statistical programming and its evolving role in ensuring robust and reliable clinical outcomes. Richardus Vonk, Biostatistics Leader, Entrepreneur, Advisor Richardus is a distinguished leader in quantitative decision-making within pharmaceutical clinical development, with over 30 years of extensive experience. He is a passionate advocate of leveraging data to enhance the success of drug development programs, emphasizing how actionable insights provide a competitive edge. Previously serving as the VP and Head of Oncology Data Analytics and Statistical Sciences at Bayer AG, Richardus now advises a diverse range of organizations in the life sciences and pharmaceutical sectors, including software companies and start-ups. He focuses on unlocking the potential of clinical and real-world data as well as advanced data-science technologies to innovate and transform the clinical trial landscape. Resources Learn more about us: https://www.verisian.com/ Join the Verisian Community: https://www.verisian.com/community Follow us on LinkedIn:   / verisian